Kumamoto, Japan

Toshio Hattori


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Kumamoto, JP (1992 - 1996)
  • Kyoto, JP (1998)

Company Filing History:


Years Active: 1992-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Toshio Hattori

Introduction

Toshio Hattori is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of medical research, particularly in the area of treatments for acquired immunodeficiency syndrome (AIDS). With a total of 3 patents to his name, Hattori's work has had a profound impact on the medical community.

Latest Patents

Hattori's latest patents include a murine monoclonal antibody that specifically binds to a glycoprotein antigen known as gp120, which is present in the envelope of the human T-lymphotropic virus III.sub.MN (HTLV-III.sub.MN). This antibody is capable of neutralizing the virus and is useful for the prophylaxis, treatment, and diagnosis of AIDS. Another significant patent involves the use of human urine trypsin inhibitor as an agent for treating or preventing AIDS. This agent can be administered intravenously for treatment and externally for prevention.

Career Highlights

Throughout his career, Hattori has worked with prominent organizations such as the Chemo-Sero-Therapeutic Research Institute and Fujisawa Pharmaceutical Company, Ltd. His research has been pivotal in advancing the understanding and treatment of AIDS.

Collaborations

Hattori has collaborated with esteemed colleagues, including Kiyoshi Takatsuki and Yasuyuki Eda, to further his research and innovations in the field.

Conclusion

Toshio Hattori's contributions to medical research, particularly in the fight against AIDS, highlight his importance as an inventor. His innovative patents and collaborations have paved the way for advancements in treatment and prevention strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…